Literature DB >> 31023073

Cardamonin Induces Cell Cycle Arrest, Apoptosis and Alters Apoptosis Associated Gene Expression in WEHI-3 Mouse Leukemia Cells.

Nien-Chieh Liao1,2,3, Yung-Luen Shih4,5,6, Jiann-Shang Chou7, Kuo-Wei Chen8, Yung-Liang Chen9, Mei-Hui Lee10, Shu-Fen Peng11, Sy-Jye Leu1,2, Jing-Gung Chung12,13.   

Abstract

Cardamonin, the chalcone class, is one of the natural components from the spicy herbaceous plant (Alpinia conchigera Griff) and has anticancer activities in many human cancer cell lines. There is, however, no information to show that cardamonin induces cell apoptosis and alters apoptosis associated gene expressions in mouse leukemia cells. Thus, we investigated the effects of cardamonin on the apoptotic cell death and associated gene expression in mouse leukemia WEHI-3 cells in vitro. Results indicated that cardamonin decreased total viable cell number via induced cell morphological changes and apoptotic cell death in WEHI-3 cells that were assay by contrast-phase microscopy and flow cytometry examinations, respectively. The flow cytometry assay indicated that cardamonin increased reactive oxygen species (ROS) and Ca 2+ production, decreased the levels of mitochondrial membrane potential ( ΔΨm) and increased caspase-3, -8 and -9 activities in WEHI-3 cells. Western blotting was performed to analyze expression of relevant pro- and anti-apoptotic proteins and results showed that cardamonin decreased anti-apoptotic protein of Bcl-2 but increased pro-apoptotic protein of Bax in WEHI-3 cells. Furthermore, cardamonin increased cytochrome c, AIF and Endo G release, increased GRP78, caspase-12 that were associated with ER stress and increased Fas, Fas-Ligand and FADD expression. Furthermore, cardamonin increased the gene expressions of DAP (death-associated protein), TMBIM4 transmembrane (BAX inhibitor motif containing 4), ATG5 (autophagy related 5) but decreased the gene expression of DDIT3 (DNA-damage inducible transcript 3), DDIT4 (DNA-damage-inducible transcript 4), BAG6 (BCL2-associated athanogene 6), BCL2L13 [BCL2-like 13 (apoptosis facilitator)] and BRAT1 (BRCA1-associated ATM activator 1) that are associated with apoptosis pathways. Based on those findings, we may suggest cardamonin induced apoptotic cell death through Fas and Fas-Ligand-, caspase- and mitochondria-dependently pathways and also affects the apoptotic gene expression in WEHI-3 cells in vitro.

Entities:  

Keywords:  Apoptosis; Cardamonin; Gene Expression; Mouse Leukemia WEHI-3 Cells; cDNA

Mesh:

Substances:

Year:  2019        PMID: 31023073     DOI: 10.1142/S0192415X19500332

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  7 in total

Review 1.  BCL2L13: physiological and pathological meanings.

Authors:  Fei Meng; Naitong Sun; Dongyan Liu; Jia Jia; Jun Xiao; Haiming Dai
Journal:  Cell Mol Life Sci       Date:  2020-11-17       Impact factor: 9.261

2.  Cardamonin inhibits cell proliferation by caspase-mediated cleavage of Raptor.

Authors:  Yanting Zhu; Jintuo Zhou; Peiguang Niu; Huajiao Chen; Daohua Shi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-10-12       Impact factor: 3.000

3.  Cardamonin suppresses pro-tumor function of macrophages by decreasing M2 polarization on ovarian cancer cells via mTOR inhibition.

Authors:  Huajiao Chen; Sheng Huang; Peiguang Niu; Yanting Zhu; Jintuo Zhou; Li Jiang; Danyun Li; Daohua Shi
Journal:  Mol Ther Oncolytics       Date:  2022-06-25       Impact factor: 6.311

Review 4.  The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases.

Authors:  Hallie M Blevins; Yiming Xu; Savannah Biby; Shijun Zhang
Journal:  Front Aging Neurosci       Date:  2022-06-10       Impact factor: 5.702

5.  In vitro selective cytotoxicity of the dietary chalcone cardamonin (CD) on melanoma compared to healthy cells is mediated by apoptosis.

Authors:  Lena Berning; Lisa Scharf; Elif Aplak; David Stucki; Claudia von Montfort; Andreas S Reichert; Wilhelm Stahl; Peter Brenneisen
Journal:  PLoS One       Date:  2019-09-25       Impact factor: 3.240

Review 6.  Emerging roles of cardamonin, a multitargeted nutraceutical in the prevention and treatment of chronic diseases.

Authors:  Uzini Devi Daimary; Dey Parama; Varsha Rana; Kishore Banik; Aviral Kumar; Choudhary Harsha; Ajaikumar B Kunnumakkara
Journal:  Curr Res Pharmacol Drug Discov       Date:  2020-12-10

Review 7.  An overview of the potential anticancer properties of cardamonin.

Authors:  Shanaya Ramchandani; Irum Naz; Namrata Dhudha; Manoj Garg
Journal:  Explor Target Antitumor Ther       Date:  2020-12-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.